Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 6/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
| ▸ | TYK2 | P29597 | 1/20 | 0.44 |
| ▸ | JAK3 | P52333 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | QPCT | Q16769 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4451470 | 0.91 | ATM (0.47) | CHRM3ATMHTTMAPTLMNA | |
| SCHEMBL1085475 | 0.89 | ALDH1A1 (0.51) | ATMHTTMAPTLMNAALDH1A1 | |
| SCHEMBL21069208 | 0.88 | ATM (0.40) | CHRM3ATMJAK2JAK1TYK2 | |
| SCHEMBL4171956 | 0.88 | JAK2 (0.48) | CHRM3ATMJAK2JAK1HTT | |
| SCHEMBL4920171 | 0.87 | CHRM3 (0.48) | CHRM3ATMHTTMAPTLMNA | |
| SCHEMBL4451146 | 0.87 | CHRM3 (0.51) | CHRM3ATMJAK2JAK1NTRK1 | |
| SCHEMBL1085544 | 0.86 | CHRM3 (0.47) | CHRM3ATMHTTMAPTLMNA | |
| SCHEMBL29445377 | 0.86 | CHRM3 (0.47) | CHRM3ATMHTTMAPTLMNA | |
| SCHEMBL4451528 | 0.85 | CHRM3 (0.48) | CHRM3ATMMAPTALDH1A1TP53 | |
| SCHEMBL303819 | 0.85 | CHRM3 (0.48) | CHRM3ATMJAK2JAK1TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | BASF AKITENGESELLSCHAFT (DE) | 2009-09-17 | — | — | US | claimed |
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | BASF AKITENGESELLSCHAFT (DE) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233795-A1 | Fungicidal Mixtres Based On 3-Monosubstituted N-Bipenyl-Pyrazolecarboxamides | CBR3, CBR1, CYCS | CHRM3 370/4885ATM 4504/4885JAK2 3619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.